Cellectis Cash from Discontinued Operations Adjustment (Quarterly) Analysis

Cellectis SA (CLLS)

3.90 -0.09 (-2.26%) USD | NASDAQ | Feb 20, 16:00

3.97 +0.07 (+1.79%) After-Hours: 20:00

View Cash from Discontinued Operations Adjustment (Quarterly) for CLLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Discontinued Operations Adjustment (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks

Start Trial

EDAP TMS SA	--
DBV Technologies SA	--
Ascendis Pharma A/S	--
Akari Therapeutics Plc	--
Biodexa Pharmaceuticals Plc	--